Psoriasis: Autoimmune Disorder Insurance Coverage

Psoriasis is an autoimmune disease. This means that the body's immune system turns on itself and attacks normal cells and tissues. In the case of psoriasis, the immune system regards skin cells as foreign and mounts an assault in the form of targeted inflammation. This causes skin cells to turn over at a vastly accelerated rate, leading to the formation of red, scaly, itchy patches recognised as plaques.

The cause of psoriasis is unknown, but both genetic and environmental factors are believed to play a role in the onset of the disease. Risk factors linked to the onset and/or exacerbation of psoriasis include a family history of psoriasis, infections, air pollution, UV damage to the skin, certain drugs, vaccines, lifestyle factors, diabetes, and having another autoimmune disease.

Psoriasis is an autoimmune disease, meaning the body's immune system attacks normal skin cells

Psoriasis is an autoimmune disease, meaning that the body's immune system attacks its own cells and tissues. In the case of psoriasis, the immune system attacks skin cells, specifically keratinocytes, which are the most abundant of all skin cells. This causes skin cells to turn over at a vastly accelerated rate, leading to the formation of thick, scaly, itchy patches known as plaques.

The exact cause of psoriasis is unknown, but it is believed to be a combination of genetic and environmental factors. The immune system's T cells, which normally combat infections, misfire and attack healthy skin cells, releasing proteins called cytokines, which cause skin cells to multiply and build up on the skin surface.

The onset of psoriasis is often triggered by environmental factors, such as an infection, which can "confuse" the immune system and cause it to regard the antigen of a normal cell as hostile.

The cause of psoriasis is unknown, but both genetic and environmental factors are believed to play a role in its onset

Genetic Factors

Psoriasis is a chronic inflammatory skin disease that affects around 2-3% of the world's population. It is believed to be multifactorial, with numerous key components, including genetic susceptibility. Results from previous family and twin studies have shown that psoriasis may run in families. If a parent, grandparent, or sibling has psoriasis, an individual has a higher chance of developing it. People with psoriasis may also have mutations or changes in specific genes, suggesting a genetic involvement in its development. Researchers have identified more than 80 genes associated with psoriasis, and different genetic changes may make specific types of psoriasis more likely.

Environmental Factors

In addition to genetic factors, environmental triggers also seem to play a role in the onset of psoriasis. These include weather changes that dry out the skin, physical trauma, drug reactivity, infection, psychological stress, obesity, smoking, and alcohol consumption.

Interactions Between Genetic and Environmental Factors

The role of the interaction between environmental factors and genetics is considered to be a main factor in the pathogenesis of psoriasis. However, it is challenging to explore the mechanisms by which environmental factors break the body's balance and affect the onset and development of psoriasis.

Psoriasis is characterised by widespread scaly erythematous plaques that cause significant physical and psychological burdens for the affected individuals

Psoriasis is a chronic inflammatory skin disease characterised by red, scaly plaques. It affects around 2-4% of the population worldwide and is associated with psoriatic arthropathy and several other health problems. The condition can cause significant physical and psychological burdens for affected individuals.

The physical symptoms of psoriasis can be minimal or very extensive, affecting the scalp, face, trunk, and limbs. It can also involve the nails (psoriatic nail dystrophy).

The psychological impact of psoriasis can be severe, affecting quality of life and daily functioning. The condition is associated with feelings of guilt, shame, embarrassment, and helplessness, as well as poor self-esteem and low self-worth, sometimes leading to social isolation. Sexual dysfunction, due to self-consciousness or painful lesions, is also common. Suicidal ideation occurs in up to 10% of patients.

The condition can also interfere with activities of daily living, including dressing, bathing, and sleeping. It may negatively impact family functioning, including financial hardship, caregiver burnout, and degeneration of patient-family relationships. Stress, which can trigger flares of psoriasis, is reported in 43-68% of patients. Depression is also common, affecting 9-55% of patients, and can lead to loss of interest in life and everyday activities, as well as negative coping mechanisms such as alcohol and drug use.

The clinical severity of psoriasis does not always correlate with its psychological impact, which can be more strongly influenced by the visibility of lesions and feelings of stigmatisation.

The psychological effects of psoriasis can be treated with psychological counselling, psychotropic medications, relaxation/stress management therapy, cognitive behavioural therapy, and hypnosis or guided imagery training. Involvement in patient support groups can also be beneficial.

Psoriasis is co-morbid with other autoimmune diseases, such as autoimmune bullous diseases, vitiligo, alopecia and thyroiditis

Psoriasis is a chronic inflammatory skin disease that affects approximately 0.5%–1% of children and 2%–3% of the world’s population. It is a bi-modally distributed disease with one major age of onset at 20–30 years of age as well as a later smaller peak of onset at 50–60 years. The exact cause of psoriasis remains unknown, but it is believed to be multifactorial with numerous key components including genetic susceptibility, environmental triggers in combination with skin barrier disruption and immune dysfunction.

Psoriasis is considered an autoimmune disease, with the immune system mistakenly attacking healthy skin cells. This causes skin cells to rapidly multiply, leading to the characteristic psoriasis skin lesions.

Psoriasis is co-morbid with other autoimmune diseases, such as:

• Alopecia areata
• Autoimmune bullous diseases
• Autoimmune thyroid disease
• Celiac disease
• Crohn's disease
• Inflammatory bowel disease
• Multiple sclerosis
• Rheumatoid arthritis
• Systemic lupus erythematosus
• Sjögren's syndrome
• Vitiligo

Psoriasis is associated with an increased risk of cardiovascular diseases and metabolic syndrome

Psoriasis is a chronic inflammatory skin disease that affects 2-3% of adults. It is associated with an increased risk of cardiovascular disease, including heart attack and stroke. This is due to the presence of metabolic syndrome, a condition that includes obesity, diabetes, high cholesterol, and hypertension, which is highly prevalent among psoriasis patients.

Psoriasis is also associated with an increased risk of other autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus.

Psoriasis is considered an autoimmune disease, with a strong genetic component. However, it is not solely a genetic disease, as environmental factors, such as physical trauma, drug reactivity, and infection, can also trigger the disease.

Frequently asked questions